About
MolecuLight Inc. is a medical technology company based in Toronto, founded in 2012 by Dr. Ralph DaCosta. The company specializes in fluorescence imaging technology, with its flagship product, the MolecuLight i:X, being a handheld device that helps clinicians identify and visualize bacterial presence in wounds in real time. This innovative technology is Health Canada-, CE-, and FDA-cleared, facilitating its use in wound care globally. The MolecuLight i:X device allows for non-invasive detection of bacteria, providing immediate insights that enhance wound diagnostics and treatment. In addition to the i:X device, MolecuLight offers accessories and software that improve clinical workflow and data management. The company is also expanding its technology for applications in surgical oncology, such as assisting in the detection of cancer cells during surgeries. MolecuLight primarily serves healthcare providers, including hospitals and wound care clinics, aiming to improve patient outcomes through precise and timely interventions.
Technologies
Keywords
Company Information
- Employees64
- Founded2013
- Annual Revenue$8000000
- Total Funding$60700000
Location
425 University Avenue, Toronto, Ontario, Canada, M5G 1T6
